Negative modulation of androgen receptor transcriptional activity by Daxx

被引:92
作者
Lin, DY
Fang, HI
Ma, AH
Huang, YS
Pu, YS
Jenster, G
Kung, HJ
Shih, HM
机构
[1] Natl Hlth Res Inst, Div Mol & Genom Med, Taipei 11529, Taiwan
[2] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan
[3] Natl Taiwan Univ, Dept Urol, Coll Med, Taipei, Taiwan
[4] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA
[5] Josephine Nefkens Inst, Erasmus Med Ctr, Dept Urol, Rotterdam, Netherlands
关键词
D O I
10.1128/MCB.24.24.10529-10541.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcriptional activity of the androgen receptor (AR) modulated by positive or negative regulators plays a critical role in controlling the growth and survival of prostate cancer cells. Although numerous positive regulators have been identified, negative regulators of AR are less well understood. We report here that Daxx functions as a negative AR coregulator through direct protein-protein interactions. Overexpression of Daxx suppressed AR-mediated promoter activity in COS-1 and LNCaP cells and AR-mediated prostate-specific antigen expression in LNCaP cells. Conversely, downregulation of endogenous Daxx expression by RNA interference enhances androgen-induced prostate-specific antigen expression in LNCaP cells. In vitro and in vivo interaction studies revealed that Daxx binds to both the amino-terminal and the DNA-binding domain of the AR. Daxx proteins interfere with the AR DNA-binding activity both in vitro and in vivo. Moreover, sumoylation of AR at its amino-terminal domain is involved in Daxx interaction and trans-repression. Together, these findings not only provide a novel role of Daxx in controlling AR transactivation activity but also uncover the mechanism underlying sumoylation-dependent transcriptional repression of the AR.
引用
收藏
页码:10529 / 10541
页数:13
相关论文
共 63 条
[31]  
Jenster G, 1999, SEMIN ONCOL, V26, P407
[32]   DOMAINS OF THE HUMAN ANDROGEN RECEPTOR INVOLVED IN STEROID BINDING, TRANSCRIPTIONAL ACTIVATION, AND SUBCELLULAR-LOCALIZATION [J].
JENSTER, G ;
VANDERKORPUT, HAGM ;
VANVROONHOVEN, C ;
VANDERKWAST, TH ;
TRAPMAN, J ;
BRINKMANN, AO .
MOLECULAR ENDOCRINOLOGY, 1991, 5 (10) :1396-1404
[33]   Protein modification by SUMO [J].
Johnson, ES .
ANNUAL REVIEW OF BIOCHEMISTRY, 2004, 73 :355-382
[34]   Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML [J].
Kim, EJ ;
Park, JS ;
Um, SJ .
NUCLEIC ACIDS RESEARCH, 2003, 31 (18) :5356-5367
[35]   Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylation [J].
Kim, J ;
Cantwell, CA ;
Johnson, PF ;
Pfarr, CM ;
Williams, SC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) :38037-38044
[36]   Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9 [J].
Komatsu, T ;
Mizusaki, H ;
Mukai, T ;
Ogawa, H ;
Baba, D ;
Shirakawa, M ;
Hatakeyama, S ;
Nakayama, KI ;
Yamamoto, H ;
Kikuchi, A ;
Morohashi, KI .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (10) :2451-2462
[37]   PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases [J].
Kotaja, N ;
Karvonen, U ;
Jänne, OA ;
Palvimo, JJ .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (14) :5222-5234
[38]   Regulation of Pax3 transcriptional activity by SUMO-1-modified PML [J].
Lehembre, F ;
Müller, S ;
Pandolfi, PP ;
Dejean, A .
ONCOGENE, 2001, 20 (01) :1-9
[39]   Sequestration and inhibition of Daxx-mediated transcriptional repression by PML [J].
Li, H ;
Leo, C ;
Zhu, J ;
Wu, XY ;
O'Neil, J ;
Park, EJ ;
Chen, JD .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (05) :1784-1796
[40]   EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes [J].
Li, RZ ;
Pei, HP ;
Watson, DK ;
Papas, TS .
ONCOGENE, 2000, 19 (06) :745-753